Sentiment-Signal
20,8
Stark Bearisch
Composite Score (0–100)
Insider (25%)
36.8
1 Insider, 259K $ Volumen
Institutionell (22,5%)
2.9
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.
Unternehmen & Branche
| Name | MANNKIND CORP |
|---|---|
| Ticker | MNKD |
| CIK | 0000899460 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 56400P201 |
|---|---|
| ISIN | US56400P2011 |
| Typ | Common Stock |
| Marktkapitalisierung | 862,8 Mio. USD |
| Beta | 1,04 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 348,966,000 | 5,863,000 | 0.02 | 792,182,000 | -51,022,000 |
| 2025-09-30 | 10-Q | 82,130,000 | 7,985,000 | 0.03 | 494,640,000 | -44,552,000 |
| 2025-06-30 | 10-Q | 76,527,000 | 668,000 | 0.00 | 411,697,000 | -55,042,000 |
| 2025-03-31 | 10-Q | 78,354,000 | 13,158,000 | 0.04 | 410,141,000 | -58,618,000 |
| 2024-12-31 | 10-K | 285,504,000 | 27,588,000 | 0.10 | 393,843,000 | -78,816,000 |
| 2024-09-30 | 10-Q | 70,079,000 | 11,550,000 | 0.04 | 464,200,000 | -209,926,000 |
| 2024-06-30 | 10-Q | 72,386,000 | -2,014,000 | -0.01 | 443,836,000 | -225,780,000 |
| 2024-03-31 | 10-Q | 66,263,000 | 10,630,000 | 0.04 | 480,879,000 | -229,970,000 |
| 2023-12-31 | 10-K | 198,962,000 | -11,938,000 | -0.04 | 475,198,000 | -246,168,000 |
| 2023-09-30 | 10-Q | 51,253,000 | 1,721,000 | 0.01 | 320,328,000 | -251,779,000 |
| 2023-06-30 | 10-Q | 48,611,000 | -5,265,000 | -0.02 | 313,422,000 | -260,487,000 |
| 2023-03-31 | 10-Q | 40,626,000 | -9,795,000 | -0.04 | 298,137,000 | -255,396,000 |
| 2022-12-31 | 10-K | 99,770,000 | -87,400,000 | -0.34 | 295,282,000 | -250,538,000 |
| 2022-09-30 | 10-Q | 32,825,000 | -14,432,000 | -0.06 | 293,837,000 | -237,677,000 |
| 2022-06-30 | 10-Q | 18,894,000 | -29,023,000 | -0.11 | 285,797,000 | -247,056,000 |
| 2022-03-31 | 10-Q | 11,992,000 | -25,998,000 | -0.10 | 308,318,000 | -232,064,000 |
| 2021-12-31 | 10-K | 75,442,000 | -80,926,000 | -0.32 | 321,161,000 | -209,349,000 |
| 2021-09-30 | 10-Q | 22,211,000 | -4,426,000 | -0.02 | 238,207,000 | -184,688,000 |
| 2021-06-30 | 10-Q | 23,280,000 | -35,523,000 | -0.14 | 252,791,000 | -183,551,000 |
| 2021-03-31 | 10-Q | 17,436,000 | -12,916,000 | 319,382,000 | -173,622,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 28,949,515 | 0 | 28,949,515 | 164,143,750 | Neu | +100,0% | |
| VANGUARD GROUP INC | 17,880,873 | 0 | 17,880,873 | 101,384,549 | Neu | +100,0% | |
| STATE STREET CORP | 14,623,269 | 0 | 14,623,269 | 82,913,935 | Neu | +100,0% | |
| Rubric Capital Management LP | 7,476,495 | 0 | 7,476,495 | 42,391,727 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 7,374,138 | 0 | 7,374,138 | 41,819,116 | Neu | +100,0% | |
| Nitorum Capital, L.P. | 5,325,823 | 0 | 5,325,823 | 30,197,416 | Neu | +100,0% | |
| UBS Group AG | 5,103,097 | 0 | 5,103,097 | 28,934,560 | Neu | +100,0% | |
| MORGAN STANLEY | 4,443,922 | 0 | 4,443,922 | 25,197,040 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 4,443,603 | 0 | 4,443,603 | 25,195,064 | Neu | +100,0% | |
| Frazier Life Sciences Management, L.P. | 4,225,000 | 0 | 4,225,000 | 23,955,750 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 3,930,355 | 0 | 3,930,355 | 22,285,113 | Neu | +100,0% | |
| FMR LLC | 3,577,534 | 0 | 3,577,534 | 20,284,620 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 3,305,012 | 0 | 3,305,012 | 18,739,418 | Neu | +100,0% | |
| 180 WEALTH ADVISORS, LLC | 2,958,944 | 0 | 2,958,944 | 16,777,214 | Neu | +100,0% | |
| CSS LLC/IL | 13,980,000 | 0 | 13,980,000 | 15,906,444 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 2,629,888 | 0 | 2,629,888 | 14,911,465 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,564,526 | 0 | 2,564,526 | 14,540,862 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2,546,034 | 0 | 2,546,034 | 14,436,013 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 2,362,221 | 0 | 2,362,221 | 13,393,792 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 1,921,967 | 0 | 1,921,967 | 10,897,552 | Neu | +100,0% | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,861,046 | 0 | 1,861,046 | 10,552,131 | Neu | +100,0% | |
| Eversept Partners, LP | 1,852,563 | 0 | 1,852,563 | 10,504,032 | Neu | +100,0% | |
| Qube Research & Technologies Ltd | 1,831,136 | 0 | 1,831,136 | 10,382,541 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 1,757,487 | 0 | 1,757,487 | 9,964,951 | Neu | +100,0% | |
| Context Capital Management, LLC | 8,060,000 | 0 | 8,060,000 | 9,148,100 | Neu | +100,0% | |
| Invesco Ltd. | 1,580,796 | 0 | 1,580,796 | 8,963,113 | Neu | +100,0% | |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,729,000 | 0 | 7,729,000 | 8,772,415 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 1,248,545 | 0 | 1,248,545 | 7,079,250 | Neu | +100,0% | |
| TWO SIGMA INVESTMENTS, LP | 1,188,438 | 0 | 1,188,438 | 6,738,443 | Neu | +100,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1,089,059 | 0 | 1,089,059 | 6,174,964 | Neu | +100,0% | |
| AXIOM INVESTORS LLC /DE | 1,037,704 | 0 | 1,037,704 | 5,883,782 | Neu | +100,0% | |
| BARCLAYS PLC | 1,025,437 | 0 | 1,025,437 | 5,814,227 | Neu | +100,0% | |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 894,204 | 0 | 894,204 | 5,070,137 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 843,026 | 0 | 843,026 | 4,779,958 | Neu | +100,0% | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 707,140 | 0 | 707,140 | 4,009,484 | Neu | +100,0% | |
| Apollo Management Holdings, L.P. | 664,113 | 0 | 664,113 | 3,765,521 | Neu | +100,0% | |
| AQR CAPITAL MANAGEMENT LLC | 639,249 | 0 | 639,249 | 3,624,541 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 610,557 | 0 | 610,557 | 3,461,858 | Neu | +100,0% | |
| Swiss National Bank | 574,700 | 0 | 574,700 | 3,258,549 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 553,759 | 0 | 553,759 | 3,139,814 | Neu | +100,0% | |
| 1492 Capital Management LLC | 535,270 | 0 | 535,270 | 3,034,981 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 522,190 | 0 | 522,190 | 2,960,817 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 512,740 | 0 | 512,740 | 2,907,236 | Neu | +100,0% | |
| Schonfeld Strategic Advisors LLC | 484,162 | 0 | 484,162 | 2,745,196 | Neu | +100,0% | |
| SEI INVESTMENTS CO | 472,859 | 0 | 472,859 | 2,681,093 | Neu | +100,0% | |
| Trexquant Investment LP | 446,930 | 0 | 446,930 | 2,534,093 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 432,785 | 0 | 432,785 | 2,453,891 | Neu | +100,0% | |
| Squarepoint Ops LLC | 427,058 | 0 | 427,058 | 2,421,419 | Neu | +100,0% | |
| VICTORY CAPITAL MANAGEMENT INC | 405,660 | 0 | 405,660 | 2,300,092 | Neu | +100,0% | |
| GROUP ONE TRADING LLC | 383,099 | 0 | 383,099 | 2,172,171 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-10 | Castagna Michael | Director, Officer, Chief Executive Officer | Open Market Purchase | 100,000 | 2.59 | 259,000.00 | +99,9% | |
| 2026-01-08 | Tross Stuart A | Officer, Chief People & Workpl Officer | Open Market Sale | -47,006 | 6.33 | -297,547.98 | -114,8% | |
| 2025-12-17 | Castagna Michael | Director, Officer, Chief Executive Officer | Open Market Sale | -65,804 | 6.01 | -395,482.04 | -152,6% | |
| 2025-12-16 | Castagna Michael | Director, Officer, Chief Executive Officer | Open Market Sale | -21,310 | 6.00 | -127,860.00 | -49,3% | |
| 2025-12-12 | Castagna Michael | Director, Officer, Chief Executive Officer | Open Market Sale | -20,806 | 6.00 | -124,836.00 | -48,2% | |
| 2025-12-02 | Castagna Michael | Director, Officer, Chief Executive Officer | Open Market Sale | -107,920 | 5.57 | -601,114.40 | -231,9% | |
| 2025-12-02 | Thomson David | Officer, EVP Genl Counsel & Secretary | Open Market Sale | -147,780 | 5.57 | -823,134.60 | -317,6% | |
| 2025-11-14 | Singh Sanjay R | Officer, EVP Technical Operations | Open Market Sale | -18,777 | 5.03 | -94,448.31 | -36,4% | |
| 2025-09-16 | Tross Stuart A | Officer, Chief People & Workpl Officer | Open Market Sale | -47,000 | 5.34 | -250,980.00 | -96,8% | |
| 2025-07-16 | Thomson David | Officer, EVP Genl Counsel & Secretary | Open Market Sale | -7,466 | 3.94 | -29,416.04 | -11,3% | |
| 2025-07-16 | Binder Steven B. | Director | Open Market Sale | -75,367 | 3.94 | -296,945.98 | -114,6% | |
| 2025-06-10 | Binder Steven B. | Director | Open Market Sale | -64,085 | 4.00 | -256,340.00 | -98,9% | |
| 2025-05-20 | Binder Steven B. | Director | Open Market Sale | -12,078 | 4.40 | -53,143.20 | -20,5% | |
| 2025-05-20 | Thomson David | Officer, EVP Genl Counsel & Secretary | Open Market Sale | -2,345 | 4.41 | -10,341.45 | -4,0% | |
| 2025-05-13 | Thomson David | Officer, EVP Genl Counsel & Secretary | Open Market Sale | -32,179 | 4.68 | -150,597.72 | -58,1% | |
| 2025-05-13 | Binder Steven B. | Director | Open Market Sale | -80,144 | 4.69 | -375,875.36 | -145,0% |
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| BlackRock, Inc. | 28,949,515 | 164,143,750 | 17.58 |
| VANGUARD GROUP INC | 17,880,873 | 101,384,549 | 10.86 |
| STATE STREET CORP | 14,623,269 | 82,913,935 | 8.88 |
| Rubric Capital Management LP | 7,476,495 | 42,391,727 | 4.54 |
| GEODE CAPITAL MANAGEMENT, LLC | 7,374,138 | 41,819,116 | 4.48 |
| Nitorum Capital, L.P. | 5,325,823 | 30,197,416 | 3.23 |
| UBS Group AG | 5,103,097 | 28,934,560 | 3.10 |
| MORGAN STANLEY | 4,443,922 | 25,197,040 | 2.70 |
| DIMENSIONAL FUND ADVISORS LP | 4,443,603 | 25,195,064 | 2.70 |
| Frazier Life Sciences Management, L.P. | 4,225,000 | 23,955,750 | 2.57 |
| CITADEL ADVISORS LLC | 3,930,355 | 22,285,113 | 2.39 |
| FMR LLC | 3,577,534 | 20,284,620 | 2.17 |
| WELLINGTON MANAGEMENT GROUP LLP | 3,305,012 | 18,739,418 | 2.01 |
| 180 WEALTH ADVISORS, LLC | 2,958,944 | 16,777,214 | 1.80 |
| CSS LLC/IL | 13,980,000 | 15,906,444 | 1.70 |
| NORTHERN TRUST CORP | 2,629,888 | 14,911,465 | 1.60 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,564,526 | 14,540,862 | 1.56 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2,546,034 | 14,436,013 | 1.55 |
| BANK OF AMERICA CORP /DE/ | 2,362,221 | 13,393,792 | 1.43 |
| GOLDMAN SACHS GROUP INC | 1,921,967 | 10,897,552 | 1.17 |